1. Procter & Gamble Health
stock logo

100% Buy

Procter & Gamble Health Share Price

PGHL

₹5,155.00+₹26.60 (0.52%) TodayLast updated on 12 Jul, 2024 | 03:29 PM IST
₹5,000.00₹5,165.40
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹8,513 Crs

Open

₹5,147.15

Close

₹5,128.40

Circuit range

₹6,154.05 - ₹4,102.75

Day range

₹5,000.00 - ₹5,165.40

Year range

₹4,636.55 - ₹5,642.85

Volume

5,556

Avg. traded

₹5,128.15

Revenue (12m)

₹1,169 Crs

Procter & Gamble HealthProcter & Gamble Health Limited is an India-based company that is primarily engaged in the manufacturing of pharmaceutical products. The Company is engaged in the manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company’s brands include Cosome, Evion, Neurobion, Seven Seas, Nasivion, Polybion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Evion range has different variants with different levels of Vitamin E, such as Evion 400, Evion 200, and Evion 600. Neurobion offers a range of neurotropic B-Vitamins which are a combination to help treat nerve damage and regenerate the nerves to relieve symptoms. Nasivion Classic Nasal Spray starts working on a blocked nose in 25 seconds. Polybion is a brand that helps with release and hence supports an active life.

Procter & Gamble Health Key indicators

arrow

52 week high

₹5,642.85

52 week low

₹4,636.55

P/E ratio

39.8

P/B ratio

10.01

ROE

33.94%

ROCE

46.07%

Dividend yield

1.85%

Debt/Equity ratio

EPS

138.23

Learn more

Investment checklist: (2/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

100%

Hold

0%

Sell

0%

This analysis is based on the reviews of 1 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

25.83%

Net profit margin

17.28%

ROE

33.94%

ROA

11%

ROCE

46.07%

Learn more

Procter & Gamble Health Shareholder returns

arrow

1 day

+0.86%

1 week

+1.58%

1 month

+2.84%

3 months

+7.70%

1 year

+2.21%

3 years

-7.49%

5 years

+26.25%

Procter & Gamble Health Share Price history

arrow
DayOpenCloseDay’s change
Thu, Jul 11 2024
₹5,184.00
₹5,128.40
-0.93%
Wed, Jul 10 2024
₹5,132.40
₹5,176.70
+0.86%
Tue, Jul 9 2024
₹5,130.75
₹5,132.40
+0.03%
Mon, Jul 8 2024
₹5,200.00
₹5,130.75
-0.85%
Fri, Jul 5 2024
₹5,169.10
₹5,174.90
+0.18%
Thu, Jul 4 2024
₹5,125.00
₹5,165.55
+1.36%
Wed, Jul 3 2024
₹5,106.05
₹5,096.30
-0.19%
Tue, Jul 2 2024
₹5,139.65
₹5,106.05
-0.06%

Shareholding info

arrow

Promoters (51.82%)

Mutual Funds (9.86%)

Retail and other (28.21%)

Foreign institutions-FII (6.24%)

Other domestic institutions (3.87%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹150/share

    Ex date 14 Feb 2024

    expand tab
  • Dividend • ₹50/share

    Ex date 14 Feb 2024

    expand tab
  • Dividend • ₹50/share

    Ex date 23 Nov 2023

    expand tab
  • Dividend • ₹50/share

    Ex date 13 Nov 2023

    expand tab
  • Dividend • ₹45/share

    Ex date 13 Feb 2023

    expand tab
  • Dividend • ₹11.5/share

    Ex date 15 Nov 2022

    expand tab
  • Dividend • ₹41/share

    Ex date 12 May 2022

    expand tab
  • Dividend • ₹90/share

    Ex date 02 Nov 2021

    expand tab

Learn more

Frequently asked questions